Crossfire Oncology
This company develops kinase inhibitors designed for precision cancer treatments, addressing drug resistance observed with first-generation inhibitors. Their research focuses on creating molecular drugs for oncology, autoimmune, and neurodegenerative diseases.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- This company develops kinase inhibitors designed for precision cancer treatments, addressing drug resistance observed with first-generation inhibitors. Their research focuses on creating molecular drugs for oncology, autoimmune, and neurodegenerative diseases.